Ontology highlight
ABSTRACT: Background
Real-life data on access and response to direct antiviral agents (DAA) in HIV-HCV coinfected individuals are lacking.Methods
HCV viremic, HIV-positive patients from Icona and Hepaicona cohorts naïve to DAA by January 2013 were included. Access and predictors of starting DAA were evaluated. Switches of antiretroviral drugs at starting DAA were described. We calculated sustained virological response (SVR12) in those reaching 12 weeks after end-of-treatment (EOT), and defined treatment failure (TF) as discontinuation of DAA before EOT or non-SVR12. Statistical analyses included Kaplan-Meier curves, univariable and multivariable analyses evaluating predictors of access to DAA and of treatment outcome (non-SVR and TF).Results
2,607 patients included. During a
SUBMITTER: d'Arminio Monforte A
PROVIDER: S-EPMC5435319 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature